Status:
COMPLETED
Work Productivity in Active Ankylosing Spondylitis (AS) Patients Treated With Enbrel.
Lead Sponsor:
Pfizer
Conditions:
Ankylosing Spondylitis
Eligibility:
All Genders
18+ years
Brief Summary
Patients with Ankylosing spondylitis more frequently discontinue work. This study measures the impact of Enbrel on work participation.
Detailed Description
Purely descriptive
Eligibility Criteria
Inclusion
- Active AS patients (as judged by the treating MD) who are currently employed.
- Patients who are scheduled by their rheumatologist to initiate treatment with Etanercept.
Exclusion
- Patients who initiated a procedure for eligibility of work disability/pension.
- Patients with previous use of TNF-alpha inhibitors either in commercial use, or in a study for the treatment of AS or a related spondylarthropathy condition.
Key Trial Info
Start Date :
October 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01421303
Start Date
October 1 2009
End Date
December 1 2013
Last Update
December 12 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitair Ziekenhuis Gent
Ghent, Gent, Belgium, 9000